Thermo Fisher ScientificTMOEarnings & Financial Report
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006.
TMO Q3 2025 Key Financial Metrics
Revenue
$11.1B
Gross Profit
N/A
Operating Profit
$1.9B
Net Profit
$1.6B
Gross Margin
N/A
Operating Margin
17.5%
Net Margin
14.5%
YoY Growth
4.9%
EPS
$4.27
Financial Flow
Thermo Fisher Scientific Q3 2025 Financial Summary
Thermo Fisher Scientific reported revenue of $11.1B for Q3 2025, with a net profit of $1.6B (14.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $11.1B |
|---|---|
| Net Profit | $1.6B |
| Gross Margin | N/A |
| Operating Margin | 17.5% |
| Report Period | Q3 2025 |
Thermo Fisher Scientific Annual Revenue by Year
Thermo Fisher Scientific annual revenue history includes year-by-year totals (for example, 2024 revenue was $42.9B).
| Year | Annual Revenue |
|---|---|
| 2024 | $42.9B |
| 2023 | $43.0B |
| 2022 | $45.3B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.89B | $10.35B | $10.54B | $10.60B | $11.39B | $10.36B | $10.86B | $11.12B |
| YoY Growth | -4.9% | N/A | -1.6% | -0.8% | N/A | 0.2% | 3.0% | 4.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $98.73B | $97.09B | $98.50B | $100.36B | $97.32B | $99.04B | $101.23B | $103.02B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $46.73B | $45.52B | $47.43B | $48.99B | $49.58B | $49.39B | $50.51B | $51.02B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.72B | $1.25B | $1.96B | $2.17B | $3.29B | $723.0M | $1.40B | $2.24B |
Other Health Care Companies
A
Agilent Technologies
Revenue
$1.9B
Net Profit
$434.0M
TECH
Bio-Techne
Revenue
$295.9M
Net Profit
$38.0M
CRL
Charles River Laboratories
Revenue
$994.2M
Net Profit
$-276.6M
DHR
Danaher Corporation
Revenue
$6.1B
Net Profit
$908.0M
IQV
IQVIA
Revenue
$4.4B
Net Profit
$514.0M
MTD
Mettler Toledo
Revenue
$1.1B
Net Profit
$285.8M
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
ABBV
AbbVie
Revenue
$15.8B
Net Profit
$186.0M
ALGN
Align Technology
Revenue
$995.7M
Net Profit
$56.8M
AMGN
Amgen
Revenue
$9.9B
Net Profit
$1.3B